Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, $0.00001 Par Value
-
Shares outstanding
-
494,239,409
-
Total 13F shares
-
8,195
-
Share change
-
-303
-
Total reported value
-
$260,000
-
Price per share
-
$31.69
-
Number of holders
-
5
-
Value change
-
-$9,603
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) as of Q3 2022
As of 30 Sep 2022,
Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,195 shares.
The largest 5 holders included
GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), BlackRock Inc., and MORGAN STANLEY.
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.